Medical Science

Promotion of the development of new methodologies leading to the novel clinical diagnosis and therapy, by utilizing innovative strategies such as iPS cells, computational simulation, and vaccine platform technologies, further using special medical industry zone in Kobe.

Research Strengths and Achievements

  • ・Research and development of the innovative medical products originated from iPS cell technology based on the knowledge of regulatory science
  • ・Research and development of novel oral vaccine platform using bifidobacteria, and the clinical development of oral hepatitis C vaccine, and oral cancer vaccine
  • ・Establishment of drug discovery system utilizing SPring-8, SACLA and computer simulation. The joint research in developing Ras inhibitors (molecular targeted anti-cancer drug candidates) with synthetic chemistry manufacture in Kobe realized the licensing out of the compound patent to the domestic pharmaceutical company.
  • ・The industry-academic alliance leveraging the special medical industry zone and the research-friendly environment with regards to pharmaceutical regulations


Typical graduates are expected to be equipped with high level of management skills, based on the specialized knowledge and skills of life science, to address unmet medical needs and to create cutting-edge medical technologies i.e., novel medicine, diagnosis, cell- and tissue-based medical products and devices.

Business Creation

  • Technology
    for Novel Drug Discovery

    Technology for Novel Drug Discovery Technology for Novel Drug Discovery
  • Technical Elements

    Technical Elements Technical Elements
  • Potential

    Potential Products Potential Products
  • Impact

    Impact Impact

Extension of healthy life expectancy by breaking through stagnant drug development with innovative technologies of Japanese origin